Email this article 
Post a Comment Prevalence of main risk factors and cytokine profile in patients with acute coronary syndrome and different serum myostatin levels
- Authors: Akhmadzyanova A.R.1, Khovaeva Y.B.1, Sosnin D.Y.1, Sobolev A.V.1, Voronova E.I.1
-
Affiliations:
- E.A. Vagner Perm State Medical University
- Issue: Vol 41, No 3 (2024)
- Pages: 42-50
- Section: Original studies
- URL: https://journal-vniispk.ru/PMJ/article/view/260567
- DOI: https://doi.org/10.17816/pmj41342-50
- ID: 260567
Cite item
Abstract
Objective. To study the prevalence of the main risk factors and the value of proinflammatory cytokines in patients with acute coronary syndrome (ACS) depending on the determined level of serum myostatin.
Materials and methods. 120 patients with ST elevation ACS (STE-ACS) and non-ST-segment elevation ACS (NSTE-ACS), hospitalized in the cardiology department of the regional vascular center were examined. In 86 patients, the level of serum myostatin and proinflammatory cytokines was determined on the 5th day of the development of acute coronary syndrome.
Results. Patients were divided into two subgroups depending on the level of serum myostatin which was determined: group 1 – with a lower level of myostatin, group 2 – with a higher level of myostatin. Group 1 (serum myostatin level from 0.038 to 0.084 ng/ml) consisted of 23 patients (16 males). Group 2 (serum myostatin level from 0.137 to 0.630 ng/ml) contained 21 patients (14 males). The main risk factors for cardiovascular diseases such as family history of early development of cardiovascular diseases, smoking, dyslipidemia, obesity, arterial hypertension and type 2 diabetes mellitus were assessed.
The levels of pro-inflammatory cytokines were determined. Tumor necrosis factor alpha (TNF-alpha) and interleukin 18 (IL-18) levels were significantly higher in patients with higher myostatin levels. Correlation analysis revealed a relationship between serum myostatin concentration and TNF-alpha level (r = 0.34; p = 0.0016).
Conclusions. No differences in the prevalence of risk factors in patients with ACS and different myostatin levels, except for smoking were revealed in the study, the frequency of smoking was higher in the group with higher myostatin levels. Greater activity of pro-inflammatory cytokines TNF-alpha and IL-18 was revealed in patients with higher levels of myostatin, as well as a significant correlation between the level of myostatin and TNF-alpha.
Full Text
##article.viewOnOriginalSite##About the authors
A. R. Akhmadzyanova
E.A. Vagner Perm State Medical University
Author for correspondence.
Email: linka949@mail.ru
ORCID iD: 0009-0004-0857-1833
Assistant of the Department of Internal Diseases and Family Medicine
Russian Federation, PermYa. B. Khovaeva
E.A. Vagner Perm State Medical University
Email: linka949@mail.ru
ORCID iD: 0000-0003-1186-3867
DSc (Medicine), Professor, Head of the Department of Internal Diseases and Family Medicine
Russian Federation, PermD. Yu. Sosnin
E.A. Vagner Perm State Medical University
Email: linka949@mail.ru
ORCID iD: 0000-0002-1232-8826
DSc (Medicine), Associate Professor, Professor of the Department of Faculty Therapy No. 2, Occupational Pathology and Clinical Laboratory Diagnostics
Russian Federation, PermA. V. Sobolev
E.A. Vagner Perm State Medical University
Email: linka949@mail.ru
PhD (Medicine), Associate Professor of the Department of Internal Diseases and Family Medicine
Russian Federation, PermE. I. Voronova
E.A. Vagner Perm State Medical University
Email: linka949@mail.ru
ORCID iD: 0000-0002-4156-9610
PhD (Medicine), Associate Professor of the Department of Internal Diseases and Family Medicine
Russian Federation, PermReferences
- Knapp M., Supruniuk E., Górski J. Myostatin and the Heart. Biomolecules. 2023 Dec 12; 13 (12): 1777. doi: 10.3390/biom13121777. PMID: 38136649; PMCID: PMC10741510.
- Mendias C.L., Gumucio J.P., Bakhurin K.I. et al. Physiological loading of tendons induces scleraxis expression in epitenon fibroblasts. J. Orthop. Res. 2012; 30 (4): 606.
- Kjær M., Langberg H., Heinemeier K. et al. From mechanical loading to collagen synthesis, structural changes and function in human tendon. Scand. J. Med. Sci. Sport. 2009; 19 (4): 500.
- Sarina Lim, Chris D. McMahon, Kenneth G. Matthews, Gerard P. Devlin, Marianne S. Elston, John V. Conaglen, Absence of Myostatin Improves Cardiac Function Following Myocardial Infarction, Heart, Lung and Circulation, 2018; 27 (6): 693–701. DOI: 10.1016/ j.hlc.2017.05.138.
- Oliveira P.G.S., Schwed J.F., Chiuso-Minicucci F., Duarte S.R.S., Nascimento L.M., Dorna M.S., Costa N.A., Okoshi K., Okoshi M.P., Azevedo P.S. et al. Association Between Serum Myostatin Levels, Hospital Mortality, and Muscle Mass and Strength Following ST-Elevation Myocardial Infarction. Heart Lung Circ. 2022; 31: 365–371.
- Головской Б.В., Берг М.Д., Булатова И.А. и др. Мышечная система в поддержании здоровья и профилактике хронических неинфекционных заболеваний. Пермский медицинский журнал 2021; 38 (1): 72–86. doi: 10.17816/pmj38172-86. EDN TPOYTR / Golovskoj B.V., Berg M.D., Bulatova I.A. The muscular system in maintaining health and preventing chronic non-infectious diseases. Perm Medical Journal 2021; 38 (1): 72–86. doi: 10.17816/pmj38172-86. EDN TPOYTR (in Russian).
- Rı́os R., Carneiro I., Arce V.M., Devesa J. Myostatin is an inhibitor of myogenic differentiation. Am J Physiol Physiol. 2002; 282 (5): C993-C999. doi: 10.1152/ajpcell.00372.2001.
- Taylor W.E., Bhasin S., Artaza J. et al. Myostatin inhibits cell proliferation and protein synthesis in C 2 C 12 muscle cells. Am J Physiol Metab. 2001; 280 (2): E221-E228. doi: 10.1152/ajpendo.2001.280.2.E221.
- Dong J., Dong Y., Chen Z., Mitch W.E., Zhang L. The pathway to muscle fibrosis depends on myostatin stimulating the differentiation of fibro/adipogenic progenitor cells in chronic kidney disease. Kidney Int. 2017; 91 (1): 119–128. doi: 10.1016/j.kint.2016.07.029.
- Shyu K.G., Lu M.J., Wang B.W. et al. Myostatin expression in ventricular myocardium in a rat model of volumeoverload heart failure. Eur. J. Clin. Invest. 2006; 36 (10): 713.
- Sharma M., Kambadur R., Matthews K.G. et al. Myostatin, a transforming growth factor-b superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. J. Cell. Physiol. 1999; 180 (1): 1.
- Lenk K., Schur R., Linke A. et al. Impact of exercise training on myostatin ex-pression in the myocardium and skeletal muscle in a chronic heart failure model. Eur. J. Heart Fail. 2009; 11 (4): 342.
- George I., Bish L.T., Kamalakkannan G. et al. Myostatin activation in patients with advanced heart failure and after mechanical unloading. Eur. J. Heart Fail. 2010; 12 (5): 444.
- Breitbart A., Auger-Messier M., Molkentin J.D., Heineke J. Myostatin from the heart: local and systemic actions in cardiac failure and muscle wasting. Am. J. Physiol. Heart Circ. Physiol. 2011; 300 (6): H1973.
- Ilich J.Z., Kelly O.J., Inglis J.E. et al. Inter-relationship amond muscle, far, fnd bone: Connecting the dots on cellular, hormonal, and whole body levels. Ageing Res Rev. 2014; 15: 51–60. doi: 10.1016/j.arr.2014.02.007 PMID: 24632496.
Supplementary files
